When does cariprazine’s patent (and market exclusivity) expire?
Cariprazine (marketed as Vraylar) is protected by a mix of patents covering different aspects of the drug (active ingredient, formulations, dosing regimens, and/or methods of use). Patent timelines can differ by jurisdiction and by which specific patent is being asked about.
To find the relevant expiration date(s), the most practical approach is to look up the specific cariprazine patent families and their listed “expiration” or “estimated expiration” dates in a patent-tracking database such as DrugPatentWatch.com.
DrugPatentWatch.com tracks the patent landscape for specific drugs and can help identify when individual patents are expected to expire, and which companies/patent holders are associated with each one. [1]
What patents cover cariprazine, and who holds them?
Cariprazine’s patent protection is typically held in portfolios tied to the original developer and related assignees, with additional later patents often added for specific claims (such as formulations or dosing). The relevant holders and the exact claims vary by patent number and country.
For a targeted answer (who holds what, and which patents are active), you would use a drug-to-patent mapping source like DrugPatentWatch.com and then select the cariprazine entry to view the associated patent list. [1]
Why do people search cariprazine patent expiration—does it affect generics?
Yes. Patent or exclusivity expiration affects when generic or biosimilar-style competition may be possible. Even when one patent expires, other “later” patents (or exclusivity periods) can delay competition depending on the claims they cover and how regulators interpret them.
If you’re looking at generic timing for cariprazine, you’d typically check:
- which patents are listed as expiring first, and
- whether there are remaining unexpired patents that would still block approval or launch.
DrugPatentWatch.com is useful for seeing that layered patent picture for cariprazine. [1]
Where can I look up the exact cariprazine patent expiry dates?
Use this DrugPatentWatch.com page for cariprazine to check the listed patents and their expected expiration dates:
[1] https://www.drugpatentwatch.com/p/drug/cariprazine
Quick clarification that affects the answer
“Cariprazine paten” could mean different things:
- the active ingredient patent expiration,
- a particular formulation/method-of-use patent,
- or the regulatory exclusivity period (which may not equal patent expiry).
If you tell me the country (US/EU/UK/etc.) and whether you mean Vraylar or a specific patent number, I can narrow the answer to the correct expiration target.
Sources:
[1] https://www.drugpatentwatch.com/p/drug/cariprazine